Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

I. Shou Chang, Shih Sheng Jiang, James Chih Hsin Yang, Wu Chou Su, Li Hsin Chien, Chin Fu Hsiao, Jih Hsiang Lee, Chih Yi Chen, Chung Hsing Chen, Gee Chen Chang, Zhaoming Wang, Fang Yi Lo, Kuan Yu Chen, Wen Chang Wang, Yuh Min Chen, Ming Shyan Huang, Ying Huang Tsai, Yu Chun Su, Wan Shan Hsieh, Wen Chi ShihShwn Huey Shieh, Tsung Ying Yang, Qing Lan, Nathaniel Rothman, Chien Jen Chen, Stephen J. Chanock, Pan Chyr Yang, Chao A. Hsiung*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science